OTCM
CPMD
Market cap1mUSD
Jul 21, Last price
0.00USD
1D
0.00%
1Q
-31.82%
Jan 2017
-99.25%
Name
CannaPharmaRx Inc
Chart & Performance
Profile
CannaPharmaRX, Inc. operates in the cannabis industry in Canada. It negotiates, acquires, and develops various cannabis cultivation projects. The company was incorporated in 1998 and is based in Calgary, Canada.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 820 | |||||||||
Cost of revenue | 557 | 1,347 | 5,501 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 264 | (1,347) | (5,501) | |||||||
NOPBT Margin | 32.14% | |||||||||
Operating Taxes | 2,693 | |||||||||
Tax Rate | ||||||||||
NOPAT | 264 | (1,347) | (8,194) | |||||||
Net income | (9,906) -368.56% | 3,688 -143.24% | (8,531) -17.49% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | 1 | 20 | 437 | |||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 7,977 | 7,200 | 8,931 | |||||||
Long-term debt | 11,660 | 11,187 | ||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 4,893 | |||||||||
Net debt | 3,456 | 14,342 | 20,037 | |||||||
Cash flow | ||||||||||
Cash from operating activities | (2,274) | (1,448) | ||||||||
CAPEX | (81) | (116) | ||||||||
Cash from investing activities | (81) | (116) | ||||||||
Cash from financing activities | 1,699 | 2,353 | 1,405 | |||||||
FCF | 13,285 | (510) | (9,281) | |||||||
Balance | ||||||||||
Cash | 2 | 650 | 2 | |||||||
Long term investments | 4,518 | 4,518 | 79 | |||||||
Excess cash | 4,479 | 4,519 | 81 | |||||||
Stockholders' equity | (100,488) | (87,980) | (91,868) | |||||||
Invested Capital | 93,548 | 88,763 | 89,049 | |||||||
ROIC | 0.29% | |||||||||
ROCE | 195.11% | |||||||||
EV | ||||||||||
Common stock shares outstanding | 625,276 | 308,938 | 211,044 | |||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | 264 | (1,219) | (5,206) | |||||||
EV/EBITDA | ||||||||||
Interest | 2,264 | 1,697 | 2,290 | |||||||
Interest/NOPBT | 858.90% |